About the Author(s)
Asmaa M. Zahran ![symbol](http://aosis.co.za/resources/publishing/images/symbol.png)
Department of Clinical Pathology, South Egypt Cancer Institute, Assiut University, Assiut, Egypt
Hanaa Nafady-Hego ![symbol](http://aosis.co.za/resources/publishing/images/symbol.png)
Department of Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt
Sawsan M. Moeen ![symbol](http://aosis.co.za/resources/publishing/images/symbol.png)
Department of Internal Medicine, Clinical Haematology Unit, Faculty of Medicine, Assiut University, Assiut, Egypt
Hanan A. Eltyb ![symbol](http://aosis.co.za/resources/publishing/images/symbol.png)
Department of Medical Oncology, South Egypt Cancer Institute, Assiut University, Assiut, Egypt
Mohammed M. Wahman ![symbol](http://aosis.co.za/resources/publishing/images/symbol.png)
Department of Clinical Oncology, South Valley University, Qena, Egypt
Asmaa Nafady ![symbol](http://aosis.co.za/resources/publishing/images/symbol.png)
Department of Clinical and Chemical Pathology, Qena Faculty of Medicine, South Valley University, Qena, Egypt
Citation
Zahran AM, Nafady-Hego H, Moeen SM, Eltyb HA, Wahman MM, Nafady A. Corrigendum: Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker. Afr J Lab Med. 2022;11(1), a1713. https://doi.org/10.4102/ajlm.v11i1.1713
Note: DOI of original article published: https://doi.org/10.4102/ajlm.v10i1.1296.
|